or Try an Advanced Search...

    Tumor Necrosis Stocks List

    Symbol Grade Name % Change
    AMGN D Amgen Inc. 0.78
    CKPT C Checkpoint Therapeutics, Inc. 4.44
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Epidermal Growth Factor Receptor Medicine Necrosis Tumor Necrosis Factor Antibodies Biotechnology Blood Cells Bone Bone Disease Cancer Care Cancer Immunotherapy Checkpoint Inhibitor Chemotherapy Clinic Dialysis Dow Jones Component Drugs Growth Factors Healthcare Providers Hematology

    Related ETFs - A few ETFs which own one or more of the above listed Tumor Necrosis stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 17.16
    BIS B ProShares UltraShort Nasdaq Biotechnology 8.14
    IBBQ D Invesco Nasdaq Biotechnology ETF 7.56
    IBB D iShares Nasdaq Biotechnology Index Fund 7.32
    MEDX F Horizon Kinetics Medical ETF 5.96
    View all Tumor Necrosis ETFs...
    Compare ETFs
    Compare BBH to IBB Compare BBH to IBBQ Compare IBB to MEDX

        Tumor Necrosis Stocks Recent News

        Date Stock Title
        Nov 21 AMGN Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
        Nov 21 AMGN Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
        Nov 21 AMGN Amgen picks prolific biotech founder Chang as new top scientist
        Nov 21 AMGN Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
        Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
        Nov 20 AMGN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
        Nov 19 AMGN Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
        Nov 19 AMGN Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
        Nov 18 AMGN Amgen Sells Off: Keep Calm And Buy The Dip
        Nov 18 AMGN Is Amgen Inc. (AMGN) the Best Immunotherapy Stock to Buy Now?
        Nov 18 AMGN Dow Tumbles Over 300 Points Following Economic Reports, Nvidia, Microsoft Decline: Fear & Greed Index Moves To 'Neutral' Zone
        Nov 16 AMGN The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
        Nov 16 AMGN 2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious
        Nov 16 AMGN The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period
        Nov 15 AMGN Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS
        Nov 15 CKPT Checkpoint Therapeutics Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$0.29 loss in 3Q 2023)
        Nov 14 CKPT Checkpoint Therapeutics: Preparing For Cosibelimab's Upcoming PDUFA Date
        Nov 14 AMGN AMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Epidermal Growth Factor Receptor Medicine Necrosis Tumor Necrosis Factor Antibodies Biotechnology Blood Cells Bone Bone Disease Cancer Care Cancer Immunotherapy Checkpoint Inhibitor Chemotherapy Clinic Dialysis Dow Jones Component Drugs Growth Factors Healthcare Providers Hematology
        Tumor Necrosis

        Tumor Necrosis is a type of cell death that occurs when cells are exposed to certain stimuli, such as radiation, chemotherapy, or certain drugs. It is a form of programmed cell death that is triggered by the body's own immune system in response to the presence of a tumor. Tumor Necrosis can be beneficial, as it can help to reduce the size of a tumor and prevent it from spreading.

        Browse All Tags